These holiday gifts change the game when building fires, printing photos, watching birds and moreIsrael launches new airstrikes on Lebanon as leaders draw closer to a ceasefire with Hezbollah
Richard Parsons, prominent Black executive who led Time Warner and Citigroup, dies at 76
OTTAWA, ON , Nov. 22, 2024 /PRNewswire/ — The Royal Canadian Mint is delighted that the one-of-a-kind 2024 10 kg 99.99% Pure Gold Coin – The Dance Screen (The Scream Too) , an exquisite numismatic tribute to the art of acclaimed Haida master carver Chief 7IDANsuu ( James Hart ), sold for $1,561,250 .00 CAD (including Buyer’s Premium), after a live auction conducted by Heffel Fine Art Auction House (Heffel). This rare, pure gold masterpiece was sold to an anonymous bidder on November 20, 2024 , and beat the previous record for a coin offered at auction in Canada , held by The Ultimate , a one kilo pure platinum coin also produced by the Royal Canadian Mint. “We are thrilled by the collector interest in this unique coin and delighted that the skill of the Royal Canadian Mint and the talent of Chief 7IDANsuu ( James Hart ) have been recognized by the buyer of this rare and beautiful 10 kg pure gold masterpiece,” said Marie Lemay , President and CEO of the Royal Canadian Mint. “It has been an extraordinary privilege to auction The Dance Screen (The Scream Too) 10kg pure gold coin,” said David Heffel , President of Heffel Fine Art Auction House. “The profoundly significant artwork by the esteemed Chief James Hart , showcased on its face, stands as an enduring icon of Canadian art, embodying the rich traditions and cultural narratives of the Haida Nation. We are honoured to have placed this masterpiece in a distinguished collection and look forward to seeing its legacy continue to inspire.” Impeccably crafted from 10 kg of 99.99% pure Canadian gold, The Dance Screen (The Scream Too) re–creates carved images from the original red cedar panel carved by Chief 7IDANsuu on its reverse. The reverse design of the flagship coin of the 2024 Opulence Collection brings together traditional Haida figures—a Shaman, the Beaver, Raven, Eagle, Frog, Orca and Mother Bear with cubs—whose life deeply depends on the Salmon, represented in human and animal form along the edge. Six pearlescent pieces of responsibly sourced abalone shell are inlayed along the coin’s edge, where their aquatic hues shimmer in the light and their shapes evoke the Haida copper shields that serve as traditional markers of wealth. The imposing coin’s obverse features the effigy of His Majesty King Charles III by Canadian artist Steven Rosati , surrounded by an engraving of subtle sketch lines from the original carving. About the Royal Canadian Mint The Royal Canadian Mint is the Crown corporation responsible for the minting and distribution of Canada’s circulation coins. The Mint is one of the largest and most versatile mints in the world, producing award-winning collector coins, market-leading bullion products, as well as Canada’s prestigious military and civilian honours. As an established London and COMEX Good Delivery refiner, the Mint also offers a full spectrum of best-in-class gold and silver refining services. As an organization that strives to take better care of the environment, to cultivate safe and inclusive workplaces and to make a positive impact on the communities where it operates, the Mint integrates environmental, social and governance practices in every aspect of its operations. For more information on the Mint, its products and services, visit www.mint.ca . Follow the Mint on LinkedIn , Facebook and Instagram . About Heffel Fine Art Auction House Since 1978, Heffel has connected passionate collectors across the world with outstanding works of art, with sales totaling nearly $1 billion . With offices in Toronto , Vancouver , Montreal , Ottawa and Calgary , Heffel has the most experienced team of fine art specialists in Canada and provides superior client service to both sellers and buyers internationally. For more information, media are asked to contact: Royal Canadian Mint, Alex Reeves , Senior Manager, Public Affairs, 613-884-6370, reeves@mint.ca ; Heffel Fine Art Auction House, Rebecca Rykiss , National Director, Brand and Communications, 416-961-6505 ext. 323, rebecca@heffel.com SOURCE Royal Canadian Mint (RCM)
NoneHow ASX dividend stocks can be the key to financial freedom
Donald Trump's unexpected reaction to Sean Hannity and Ainsley Earhardt's engagementNavy gets 95-yard TD run from Horvath and stops 2-point try to beat Oklahoma in Armed Forces Bowl
At least this NFL game wasn't on Christmas -- because it was far from merry. Just a day after the Houston Texans posted only two points in a blowout loss to the Baltimore Ravens , the Seattle Seahawks and Chicago Bears closed out the Thursday Night Football schedule with a whimper. Seattle moved to 9-7 with a lackluster 6-3 victory over Chicago, which dropped its 10th straight game to fall to 4-12 after a promising 4-2 start. All field goals were scored in the first half. Chicago quarterback Caleb Williams had the chance to steal the game at home late and ruin Seattle's playoff chances, but failed. Let's analyze the Week 17 game further with winners and losers: While Geno Smith didn't have an impressive showing -- he completed 17 of 23 passes for 160 yards, no touchdowns, no picks and three sacks -- the running game did its part to win on the margins. Zach Charbonnet led the way with 57 yards on 15 rushes, but backup Kenny McIntosh came up big with 46 yards on seven attempts, pioneered by a 25-yarder. Smith added 19 yards on three carries, making it 122 total on 25 attempts for Seattle on the night. For comparison's sake, Chicago finished at 103 yards on 23 carries after D'Andre Swift ended the game on a positive note. The game is all about the moments. Despite the score being at 6-3 and no teams capitalizing throughout, the game fell on the shoulders of Williams for a chance to win at home right after Christmas. Instead, Williams capped off his disappointing night with a pick. On a 4th-and-10, Williams felt immediate pressure on a blitz and lofted up a ball toward Keenan Allen. But Riq Woolen soared over Allen and brought down the pick. Sure, maybe the draft pick for Chicago would be better long term. However, it'd also be encouraging to see Williams lead a game-winning drive as a rookie. He ended the game completing 16 of 28 passes for 122 yards, no touchdowns and the above pick. He took seven sacks. Having a good kicker is extremely important. It matters even more so in games like this, where one missed kick could prove costly. Both Seattle's Jason Myers and Chicago's Cairo Santos earned their paycheck, albeit in an awkward way. Myers made both his attempts, the longest being from 50 yards. Santos made his lone attempt, which was from 42. A win is a win, but how those wins are earned could go a long way in predicting playoff chances. Seattle entered the game needing a win to put the pressure on the 9-6 Los Angeles Rams . But this showing will likely not improve confidence levels much moving forward, with the team needing the Rams to lose to the already-eliminated Arizona Cardinals on Sunday to set up a blockbuster NFC West title match in Week 18. But if the Rams win, Seattle needs four wins from the Green Bay Packers, New York Jets , Detroit Lions, Atlanta Falcons, Denver Broncos or Miami Dolphins for strength-of-schedule purposes heading into Week 18, where a Seattle road win over Los Angeles could be enormous in the NFC West picture.Natera, Inc. ( NASDAQ:NTRA – Get Free Report ) insider John Fesko sold 669 shares of Natera stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $159.60, for a total value of $106,772.40. Following the completion of the sale, the insider now directly owns 114,142 shares in the company, valued at $18,217,063.20. This represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website . Natera Stock Performance Shares of NTRA stock opened at $160.26 on Friday. The company has a market capitalization of $21.16 billion, a price-to-earnings ratio of -91.06 and a beta of 1.63. The company has a debt-to-equity ratio of 0.33, a quick ratio of 4.23 and a current ratio of 4.39. Natera, Inc. has a 52 week low of $58.53 and a 52 week high of $175.63. The company has a 50-day simple moving average of $150.16 and a 200 day simple moving average of $127.78. Natera ( NASDAQ:NTRA – Get Free Report ) last posted its earnings results on Tuesday, November 12th. The medical research company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.57) by $0.31. The company had revenue of $439.80 million for the quarter, compared to the consensus estimate of $361.43 million. Natera had a negative return on equity of 26.23% and a negative net margin of 14.01%. The firm’s revenue for the quarter was up 63.9% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.95) earnings per share. On average, sell-side analysts predict that Natera, Inc. will post -1.61 earnings per share for the current year. Institutional Investors Weigh In On Natera Wall Street Analyst Weigh In A number of equities research analysts recently issued reports on the company. Leerink Partners lifted their target price on Natera from $140.00 to $150.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Piper Sandler boosted their price objective on shares of Natera from $150.00 to $200.00 and gave the stock an “overweight” rating in a research report on Monday, November 18th. The Goldman Sachs Group raised their target price on shares of Natera from $125.00 to $140.00 and gave the company a “buy” rating in a research report on Wednesday, October 16th. TD Cowen boosted their price target on shares of Natera from $155.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Finally, Robert W. Baird raised their price objective on Natera from $120.00 to $160.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a sell rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $152.67. Read Our Latest Research Report on NTRA About Natera ( Get Free Report ) Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. Featured Articles Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter .A ninth U.S. telecoms firm has been confirmed to have been hacked as part of a sprawling Chinese espionage campaign that gave officials in Beijing access to private texts and phone conversations of an unknown number of Americans, a top White House official said Friday. Biden administration officials said this month that at least eight telecommunications companies, as well as dozens of nations, had been affected by the Chinese hacking blitz known as Salt Typhoon. > Watch NBC Bay Area News 📺 Streaming free 24/7 But deputy national security adviser Anne Neuberger told reporters Friday that a ninth victim had been identified after the administration released guidance to companies about how to hunt for Chinese culprits in their networks. The update from Neuberger is the latest development in a massive hacking operation that has alarmed national security officials, exposed cybersecurity vulnerabilities in the private sector and laid bare China 's hacking sophistication. The hackers compromised the networks of telecommunications companies to obtain customer call records and gain access to the private communications of what officials have said is a a limited number of individuals. Though the FBI has not publicly identified any of the victims, officials believe senior U.S. government officials and prominent political figures are among those whose whose communications were accessed. Neuberger said Friday that officials did not yet have a precise sense how many Americans overall were affected by Salt Typhoon, in part because the Chinese were careful about their techniques, but that a “large number" were in the Washington-Virginia area. Officials believe the goal of the hackers was to identify who owned the phones and, if they were “government targets of interest,” spy on their texts and phone calls, she said. The FBI said most of the people targeted by the hackers are "primarily involved in government or political activity.” Neuberger said the episode highlighted the need for required cybersecurity practices in the telecommunications industry, something the Federal Communications Commission is to take up at a meeting next month. In addition, she said, the government was planning additional actions in coming weeks in response to the hacking campaign, though she did not say what they were. “We know that voluntary cyber security practices are inadequate to protect against China, Russia and Iran hacking of our critical infrastructure,” she said. The Chinese government has denied responsibility for the hacking.
South Korean President Yoon Suk Yeol's impeachment trial begins at the Constitutional Court on Friday. The case revolves around his controversial imposition of martial law, which has attracted widespread criticism. Yoon's refusal to cooperate with court summonses has drawn ire from both political opponents and members of his own party. Legal representatives, including a former prosecutor and ex-spokesman for the Constitutional Court, will attend the hearing on his behalf. The political crisis has significant implications for South Korea's international relations, with allies such as the United States and Europe expressing concern. The outcome of this trial will determine whether Yoon remains in office or if a new presidential election will be called. (With inputs from agencies.)
Exagen Inc. ( NASDAQ:XGN – Get Free Report ) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 78,100 shares, an increase of 36.5% from the November 30th total of 57,200 shares. Currently, 0.9% of the company’s stock are short sold. Based on an average daily volume of 82,200 shares, the days-to-cover ratio is presently 1.0 days. Exagen Price Performance Shares of Exagen stock opened at $4.71 on Friday. The firm has a fifty day moving average price of $3.84 and a two-hundred day moving average price of $2.98. The company has a market cap of $83.07 million, a PE ratio of -5.01 and a beta of 1.49. The company has a debt-to-equity ratio of 1.54, a current ratio of 4.05 and a quick ratio of 4.05. Exagen has a fifty-two week low of $1.30 and a fifty-two week high of $6.22. Exagen ( NASDAQ:XGN – Get Free Report ) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.02. Exagen had a negative return on equity of 92.58% and a negative net margin of 30.36%. The firm had revenue of $12.51 million for the quarter, compared to analyst estimates of $13.55 million. During the same period in the previous year, the company posted ($0.31) earnings per share. Analysts expect that Exagen will post -0.87 EPS for the current year. Wall Street Analyst Weigh In Read Our Latest Stock Analysis on Exagen Insider Buying and Selling In other news, major shareholder Nmsic Co-Investment Fund, L.P. sold 200,000 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $3.30, for a total transaction of $660,000.00. Following the completion of the sale, the insider now directly owns 2,108,958 shares of the company’s stock, valued at $6,959,561.40. This trade represents a 8.66 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink . Also, CEO John Aballi purchased 24,305 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was purchased at an average cost of $2.81 per share, with a total value of $68,297.05. Following the purchase, the chief executive officer now owns 689,799 shares in the company, valued at $1,938,335.19. This represents a 3.65 % increase in their position. The disclosure for this purchase can be found here . 26.10% of the stock is currently owned by corporate insiders. Institutional Inflows and Outflows Hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC grew its position in Exagen by 93.3% during the 2nd quarter. Renaissance Technologies LLC now owns 94,234 shares of the company’s stock worth $172,000 after acquiring an additional 45,476 shares during the last quarter. Creative Planning acquired a new position in Exagen in the third quarter worth $110,000. Palumbo Wealth Management LLC grew its holdings in shares of Exagen by 14.5% during the third quarter. Palumbo Wealth Management LLC now owns 76,364 shares of the company’s stock worth $236,000 after purchasing an additional 9,695 shares during the last quarter. Verus Capital Partners LLC acquired a new stake in shares of Exagen in the third quarter valued at $39,000. Finally, Stonepine Capital Management LLC increased its stake in shares of Exagen by 49.0% in the third quarter. Stonepine Capital Management LLC now owns 534,398 shares of the company’s stock valued at $1,651,000 after buying an additional 175,701 shares in the last quarter. Institutional investors and hedge funds own 75.25% of the company’s stock. About Exagen ( Get Free Report ) Exagen Inc develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Featured Articles Receive News & Ratings for Exagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exagen and related companies with MarketBeat.com's FREE daily email newsletter .star has shared the struggles he faced during his recent illness, which led to a significant weight loss and left him too weak to play. In an interview with The Athletic, described his ordeal: "I've never been that sick before in my entire life. I didn't eat for two days, didn't get up, nothing. I was down. It was bad." revealed that he initially aimed to return earlier against the but couldn't due to persistent breathing issues and severe coughing. "I got through the workout, but I couldn't breathe good," he admitted. His absence, combined with the recovery period, left the veteran nervous about returning to the court. This marks first game since December 14, where he played against the . So far this season, the 34-year-old has averaged 25.7 points, 7.5 assists, and 4.5 rebounds across 22 games, forming a formidable duo with teammate . However, own illness has him listed as questionable for tonight's matchup. Bucks' redemption arc Despite a rough start to the season, remains optimistic. Reflecting on the team's early struggles, he stated: "The team we started the season as is not the team that we are now. And it was never who we truly were." Since their 2-8 start, the have improved to a 16-13 record, showing signs of the championship-caliber play expected from them. was pivotal in the victory, contributing 23 points, four rebounds, and four assists in the final against the . His partnership with has become a beacon of hope for , signaling their potential to climb even higher in the standings. Crucial games ahead The face the tonight, followed by matchups against teams like the . With return and a chance to build momentum, aims to solidify their playoff position and silence any lingering doubts about their capabilities. resilience and return couldn't come at a more critical time for the as they look to continue their upward trajectory in the .Roadrunner Transportation Systems, Inc. ( OTCMKTS:RRTS – Get Free Report ) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 7,400 shares, a decrease of 22.1% from the November 30th total of 9,500 shares. Based on an average daily trading volume, of 31,800 shares, the short-interest ratio is currently 0.2 days. Roadrunner Transportation Systems Stock Performance Shares of OTCMKTS RRTS opened at $3.00 on Friday. Roadrunner Transportation Systems has a one year low of $0.97 and a one year high of $3.36. The business has a fifty day simple moving average of $1.67 and a 200 day simple moving average of $1.43. Roadrunner Transportation Systems Company Profile ( Get Free Report ) See Also Receive News & Ratings for Roadrunner Transportation Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roadrunner Transportation Systems and related companies with MarketBeat.com's FREE daily email newsletter .
A judge on Monday rejected a request to block a San Jose State women's volleyball team member from playing in a conference tournament on grounds that she is transgender. The ruling by U.S. Magistrate Judge S. Kato Crews in Denver will allow the player, who has played all season, to compete in the Mountain West Conference women's championship opening this week in Las Vegas. The ruling comes in a lawsuit filed by nine current players against the Mountain West Conference challenging the league's policies for allowing transgender players to participate. The players argued that letting her compete was a safety risk and unfair. While some media have reported those and other details, neither San Jose State nor the forfeiting teams have confirmed the school has a trans woman volleyball player. The Associated Press is withholding the player's name because she has not commented publicly on her gender identity. School officials also have declined an interview request with the player. Crews' ruling referred to the athlete as an "alleged transgender" player and noted that no defendant disputed that the San Jose State roster includes a transgender woman player. San Jose State will "continue to support its student-athletes and reject discrimination in all forms," the university said in a statement, confirming that all its student-athletes are eligible to participate under NCAA and conference rules. "We are gratified that the Court rejected an eleventh-hour attempt to change those rules. Our team looks forward to competing in the Mountain West volleyball tournament this week." The conference did not immediately respond to an email seeking comment. The players filed a notice for emergency appeal with the 10th U.S. Circuit Court of Appeals. Crews said the players who filed the complaint could have sought relief much earlier, noting the individual universities had acknowledged that not playing their games against San Jose State this season would result in a loss in league standings. He also refused a request to re-seed the tournament without the forfeited losses. The judge said injunctions are meant to preserve the status quo. The conference policy regarding forfeiting for refusing to play against a team with a transgender player had been in effect since 2022 and the San Jose State player has been on the roster since 2022 -– making that the status quo. The player competed at the college level three previous seasons, including two for San Jose State, drawing little attention. This season's awareness of her reported identity led to an uproar among some players, pundits, parents and politicians in a major election year. Crews' ruling also said injunctions are meant to prevent harm, but in this case, he argued, the harm has already occurred. The games have been forfeited, the tournament has been seeded, the teams have made travel plans and the participants have confirmed they're playing. The tournament starts Wednesday and continues Friday and Saturday. Colorado State is seeded first and San Jose State, second. The teams split their regular-season matches and both get byes into Friday's semifinals. San Jose State will play the winner of Wednesday's match between Utah State and Boise State — teams that both forfeited matches to SJSU during the regular season. Boise State associate athletic director Chris Kutz declined to comment on whether the Broncos would play SJSU if they won their first-round tournament game. Utah State officials did not immediately respond to emails seeking comment. The conference tournament winner gets an automatic bid to the NCAA tournament. San Jose State coach Todd Kress, whose team has not competed in the national tournament since 2001, has said his team has been getting "messages of hate" and that has taken a toll on his players. Several teams refused to play against San Jose State during the season, earning losses in the official conference standings. Boise State and Wyoming each had two forfeits while Utah State and Nevada both had one. Southern Utah, a member of the Western Athletic Conference, was first to cancel against San Jose State this year. Nevada's players stated they "refuse to participate in any match that advances injustice against female athletes," without elaborating. Nevada did not qualify for the conference tournament. The nine current players and others now suing the Mountain West Conference, the California State University Board of Trustees and others include San Jose State senior setter and co-captain Brooke Slusser. The teammate Slusser says is transgender hits the volleyball with more force than others on the team, raising fear during practices of suffering concussions from a head hit, the complaint says. The Independent Council on Women's Sports is funding a separate lawsuit against the NCAA for allowing transgender women to compete in women's sports. Both lawsuits claim the landmark 1972 federal antidiscrimination law known as Title IX prohibits transgender women in women's sports. Title IX prohibits sexual discrimination in federally funded education; Slusser is a plaintiff in both lawsuits. Several circuit courts have used a U.S. Supreme Court ruling to conclude that discriminating against someone based on their transgender status or sexual orientation is sex-based discrimination, Crews wrote. That means case law does not prove the "likelihood of success" needed to grant an injunction. An NCAA policy that subjects transgender participation to the rules of sports governing bodies took effect this academic year. USA Volleyball says a trans woman must suppress testosterone for 12 months before competing. The NCAA has not flagged any issues with San Jose State. The Republican governors of Idaho, Nevada, Utah and Wyoming have made public statements in support of the team cancellations, citing fairness in women's sports. President-elect Donald Trump likewise has spoken out against allowing transgender women to compete in women's sports. Crews was a magistrate judge in Colorado's U.S. District Court for more than five years before President Joe Biden appointed him as a federal judge in January. Get local news delivered to your inbox!Power Corp. of Canada stock falls Monday, underperforms market